Biochem Flashcards
primary hyperlipoproteinemias: Sitosterolemia
gene mutation:ABCG5
ABCG8
Elevated lipoproteins: LDL
Sx: Tendon xanthomas, CDH
incidence: <1/1mil
primary hyperlipoproteinemias: familial hypercholesterolemia
gene mutation: LDL receptor
Elevated lipoproteins: LDL
Sx: Tendon xanthomas, CDH
incidence: 1/500
primary hyperlipoproteinemias: familial dysbetalipoproteinemia
gene mutation: Ape
Elevated lipoproteins: Chylomicrons
VLDL remnants
Sx: Palmar and tuberoeruptive xanthomas, CHD, PVD
incidence: 1/10,000
primary hyperlipoproteinemias: familial hypertriglyceridemia
gene mutation: Unknown (ApoA-V? LPL or apoC-2?)
Elevated lipoproteins: VLDL and plasma triglycerides
Sx: early coronary artery disease
incidence: 1/500
Describe the diagnostic tests for: homozygous familial hypercholesterolemia
Skin biopsy measures LDL receptor activity in fibroblasts
Cell sorting measures LDL receptors on lymphocytes
DNA sequencing defines mutations in LDL receptor
Describe the diagnostic tests for: Sitosterolemia
High plasma sitosterol on gas chromatography
Describe the diagnostic tests for:familial dysbetalipoproteinemia
Lipoprotein electrophoresis
Ultracentrifugation
apoE phenotyping/genotyping
Describe the diagnostic tests for : familial hypertriglyceridemia
High plasma triglycerides
Normal cholesterol
Low plasma HDL-C
treatment options for hyperlipoproteinemias: effects of Diet and exercise
Lower triglyceride levels
treatment options for hyperlipoproteinemias: Fibrate drugs (fibric acid derivatives: gemfibrozil, fenofibrate)
Increase LPL (lipoprotein lipase) and decrease VLDL synthesis
treatment options for hyperlipoproteinemias: Fish/flaxseed oils (omega 3 fatty acids)
Increase triglyceride catabolism; increase plasma LDL-C
treatment options for hyperlipoproteinemias: Niacin (nicotinic acid)
Decrease VLDL production; agonist of PPARa a regulator of lipid metabolism
treatment options for hyperlipoproteinemias: Statins (lovastatin, pravastatin, simvastatin)
Inhibit HMG-CoA reductase= decrease cholesterol biosynthesis; increase hepatic LDL receptors
treatment options for hyperlipoproteinemias: Ezelimibe
Inhibit cholesterol absorption in small intestine by LDL receptors
treatment options for hyperlipoproteinemias: Bile acid sequestrants (sholestyramine, cholestipol)
Increase bile acid excretion and increase LDL receptors